{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:42:15Z","timestamp":1793900535108,"version":"4.8.0"},"reference-count":40,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCR"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>The globalization of the Western lifestyle has resulted in increase of diabetes mellitus, a\ncomplex, multifactorial disease. Diabetes mellitus is a condition often related to the disorders of the\ncardiovascular system. It is well established that three quarters of diabetics, aged over 40, will die\nfrom cardiovascular disease and are more likely than non-diabetics to die from their first cardiovascular\nevent. Therefore, it is of paramount importance to individualize treatment via risk stratification.\nConditions that increase cardiovascular risk in people with diabetes include age more than 40\nyears, male gender, history of relative suffering from premature CHD, blood pressure and high\nLDL levels, presence of microalbuminuria, obstructive sleepapnea, erectile dysfunction and other\nconditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Several models have been developed in order to assess cardiovascular risk in people with and without\ndiabetes. Some of them have been proven to be inadequate while others are widely used for\nyears. An emerging way of risk assessment in patients with diabetes mellitus is the use of biomarkers\nbut a lot of research needs to be done in this field in order to have solid conclusions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1573403x15666191111123622","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T07:48:11Z","timestamp":1573544891000},"page":"266-274","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Assessing Cardiovascular Risk in Patients with Diabetes: An Update"],"prefix":"10.2174","volume":"16","author":[{"given":"Christos","family":"Damaskos","sequence":"first","affiliation":[{"name":"Second Department of Propedeutic Surgery, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Garmpis","sequence":"additional","affiliation":[{"name":"Second Department of Propedeutic Surgery, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Kollia","sequence":"additional","affiliation":[{"name":"1st Department of Otorhinolaryngology, University of Athens, Hippokration Hospital of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Mitsiopoulos","sequence":"additional","affiliation":[{"name":"Health Center Acharnes, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danai","family":"Barlampa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Pamakaristos Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Drosos","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, KAT General Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Patsouras","sequence":"additional","affiliation":[{"name":"Second Department of Propedeutic Surgery, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Gravvanis","sequence":"additional","affiliation":[{"name":"Health Center Peristeriou, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Antoniou","sequence":"additional","affiliation":[{"name":"Breast Surgical Clinic, Saint Savvas Anti-Cancer Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Litos","sequence":"additional","affiliation":[{"name":"Dromokaiteio Psychiatric Hospital, Chaidari 124 61, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6235-8487","authenticated-orcid":true,"given":"Evangelos","family":"Diamantis","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes Center, \"G. Gennimatas\", General Hospital of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13098-017-0225-1","volume":"9","author":"Bertoluci M.","year":"2017","unstructured":"Bertoluci M.; Rocha V.; Cardiovascular risk assessment in patients with diabetes. Diabetol Metab Syndr 2017,9,25","journal-title":"Diabetol Metab Syndr"},{"key":"ref=2","first-page":"S2","volume":"111","author":"Baldwin M.","year":"2011","unstructured":"Baldwin M.; Assessing cardiovascular risk factors and selecting agents to successfully treat patients with type 2 diabetes mellitus. JAOA 2011,111(2),S2-S12","journal-title":"JAOA"},{"key":"ref=3","first-page":"258","volume":"22","author":"Mansour A.A.","year":"2015","unstructured":"Mansour A.A.; Douri F.A.; Diabetes in Iraq: Facing the epidemic. A systematic review. Wulfernia 2015,22(3),258-273","journal-title":"Wulfernia"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"634","DOI":"10.4239\/wjd.v6.i4.634","volume":"6","author":"Lam T.","year":"2015","unstructured":"Lam T.; Burns K.; Dennis M.; Cheung N.W.; Gunton J.E.; Assessment of cardiovascular risk in diabetes: Risk scores and provocative testing. World J Diabetes 2015,6(4),634-641","journal-title":"World J Diabetes"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","volume":"3","author":"Shah A.D.","year":"2015","unstructured":"Shah A.D.; Langenberg C.; Rapsomaniki E.; Type 2 diabetes and incidence of cardiovascular diseases: A cohort study in 1\u20229 million people. Lancet Diabetes Endocrinol 2015,3(2),105-113","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s13300-019-0612-8","volume":"10","author":"Schofield J.","year":"2019","unstructured":"Schofield J.; Ho J.; Soran H.; Cardiovascular risk in type 1 diabetes mellitus. Diabetes Ther 2019,10(3),773-789","journal-title":"Diabetes Ther"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"Ryd\u00e9n L.","year":"2013","unstructured":"Ryd\u00e9n L.; Grant P.J.; Anker S.D.; ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013,34(39),3035-3087","journal-title":"Eur Heart J"},{"key":"ref=8","author":"Moser M.","year":"2002","unstructured":"Moser M.;  The treatment of hypertension A story of myths, misconceptions, controversies and heroics 2002","journal-title":"The treatment of hypertension A story of myths, misconceptions, controversies and heroics"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/0021-9681(67)90082-3","volume":"20","author":"Truett J.","year":"1967","unstructured":"Truett J.; Cornfield J.; Kannel W.; A multivariate analysis of the risk of coronary heart disease in Framingham. J Chronic Dis 1967,20(7),511-524","journal-title":"J Chronic Dis"},{"key":"ref=10","year":"1973","unstructured":"Coronary risk handbook: Estimating risk of coronary heart disease in daily practice American Heart Association1973","journal-title":"Coronary risk handbook: Estimating risk of coronary heart disease in daily practice"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/0002-9149(76)90061-8","volume":"38","author":"Kannel W.B.","year":"1976","unstructured":"Kannel W.B.; McGee D.; Gordon T.; A general cardiovascular risk profile: The Framingham Study. Am J Cardiol 1976,38(1),46-51","journal-title":"Am J Cardiol"},{"key":"ref=12","author":"Pickering G.","year":"1961","unstructured":"Pickering G.;  The nature of essential hypertension 1961","journal-title":"The nature of essential hypertension"},{"key":"ref=13","first-page":"86","volume":"136","author":"Brittain E.","year":"1982","unstructured":"Brittain E.; Probability of coronary heart disease developing. West J Med 1982,136(1),86-89","journal-title":"West J Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","volume":"97","author":"Wilson P.W.","year":"1998","unstructured":"Wilson P.W.; D\u2019Agostino R.B.; Levy D.; Belanger A.M.; Silbershatz H.; Kannel W.B.; Prediction of coronary heart disease using risk factor categories. Circulation 1998,97(18),1837-1847","journal-title":"Circulation"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"D\u2019Agostino R.B.","year":"2008","unstructured":"D\u2019Agostino R.B.; Vasan R.S.; Pencina M.J.; General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation 2008,117(6),743-753","journal-title":"Circulation"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1001\/archinternmed.2009.434","volume":"170","author":"Ferket B.S.","year":"2010","unstructured":"Ferket B.S.; Colkesen E.B.; Visser J.J.; Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check? Arch Intern Med 2010,170(1),27-40","journal-title":"Arch Intern Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"i2416","DOI":"10.1136\/bmj.i2416","volume":"353","author":"Damen J.A.A.G.","year":"2016","unstructured":"Damen J.A.A.G.; Hooft L.; Schuit E.; Prediction models for cardiovascular disease risk in the general population: Systematic review. BMJ 2016,353,i2416","journal-title":"BMJ"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.pcad.2010.04.001","volume":"53","author":"Bitton A.","year":"2010","unstructured":"Bitton A.; Gaziano T.A.; The Framingham Heart Study\u2019s impact on global risk assessment. Prog Cardiovasc Dis 2010,53(1),68-78","journal-title":"Prog Cardiovasc Dis"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/HJR.0b013e328011490","volume":"14","author":"Lindman A.S.","year":"2007","unstructured":"Lindman A.S.; Veierod M.B.; Pedersen J.I.; The ability of the SCORE high-risk model to predict 10-year cardiovascular disease mortality in Norway. Eur J Cardiovasc Prev Rehabil 2007,14(4),501-507","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/ijo.2008.29","volume":"32","author":"Assmann G.","year":"2008","unstructured":"Assmann G.; Schulte H.; Seedorf U.; Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular M\u00fcnster (PROCAM) Study. Int J Obes(Lond) 2008,32(Suppl. 2),S11-S16","journal-title":"Int J Obes(Lond)"},{"key":"ref=21","doi-asserted-by":"publisher","unstructured":"ippisley-Cox J, Coupland C, Vinogradova Y, et al. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: A validation study. Heart 2008; 94(1): 34-9.","DOI":"10.1136\/hrt.2007.134890"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/hrt.2006.108167","volume":"93","author":"Woodward M.","year":"2007","unstructured":"Woodward M.; Brindle P.; Tunstall-Pedoe H.; Adding social deprivation and family history to cardiovascular risk assessment: The ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 2007,93(2),172-176","journal-title":"Heart"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.2337\/dc06-1358","volume":"30","author":"Coleman R.L.","year":"2007","unstructured":"Coleman R.L.; Stevens R.J.; Retnakaran R.; Holman R.R.; Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes. Diabetes Care 2007,30(5),1292-1293","journal-title":"Diabetes Care"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11886-017-0831-4","volume":"19","author":"Saeed A.","year":"2017","unstructured":"Saeed A.; Ballantyne C.M.; Assessing cardiovascular risk and testing in type 2 diabetes. Curr Cardiol Rep 2017,19,19","journal-title":"Curr Cardiol Rep"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4239\/wjd.v7.i18.423","volume":"7","author":"Di Pino A.","year":"2016","unstructured":"Di Pino A.; Urbano F.; Piro S.; Purrello F.; Rabuazzo A.M.; Update on pre-diabetes: Focus on diagnostic criteria and cardiovascular risk. World J Diabetes 2016,7(18),423-432","journal-title":"World J Diabetes"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.2215\/CJN.09540916","volume":"11","author":"Dixon B.S.","year":"2016","unstructured":"Dixon B.S.; Is change in albuminuria a surrogate marker for cardiovascular and renal outcomes in type 1 diabetes? Clin J Am Soc Nephrol 2016,11(11),1921-1923","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/2047487316676134","volume":"24","author":"Carlsson AC","year":"2017","unstructured":"Carlsson AC; Sundstr\u20acom J, Carrero JJ, et al. Use of a proximity extension assay proteomics chip to discover new biomarkers associated with albuminuria. Eur J Prev Cardiol 2017,24(4),340-348","journal-title":"Eur J Prev Cardiol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ijcard.2015.06.003","volume":"197","author":"Yang Z.K.","year":"2015","unstructured":"Yang Z.K.; Shen Y.; Shen W.F.; Elevated glycated albumin and reduced endogenous secretory receptor for advanced glycation end-products levels in serum predict major adverse cardio-cerebral events in patients with type 2 diabetes and stable coronary artery disease. Int J Cardiol 2015,197,241-247","journal-title":"Int J Cardiol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.dsx.2019.01.018","volume":"13","author":"Berezin A.E.","year":"2019","unstructured":"Berezin A.E.; Prognostication of clinical outcomes in diabetes mellitus: Emerging role of cardiac biomarkers. Diabetes Metab Syndr 2019,13,995-1003","journal-title":"Diabetes Metab Syndr"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(06)68967-8","volume":"368","author":"Booth G.L.","year":"2006","unstructured":"Booth G.L.; Kapral M.K.; Fung K.; Tu J.V.; Relation between age and cardiovascular disease in men and women with diabetes compared with nondiabetic people: A population-based retrospective cohort study. Lancet 2006,368(9529),29-36","journal-title":"Lancet"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/bmj.38678.389583.7C","volume":"332","author":"Huxley R.","year":"2006","unstructured":"Huxley R.; Barzi F.; Woodward M.; Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006,332(7533),73-78","journal-title":"BMJ"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1001\/jama.2010.461","volume":"303","author":"Polonsky T.S.","year":"2010","unstructured":"Polonsky T.S.; McClelland R.L.; Jorgensen N.W.; Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 2010,303(16),1610-1616","journal-title":"JAMA"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","volume":"129","author":"Goff D.C.","year":"2014","unstructured":"Goff D.C.; Lloyd-Jones D.M.; Bennett G.; 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines. Circulation 2014,129(25)(Suppl. 2),S49-S73","journal-title":"Circulation"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ijcard.2011.12.100","volume":"167","author":"Qin R.","year":"2013","unstructured":"Qin R.; Chen T.; Lou Q.; Yu D.; Excess risk of mortality and cardiovascular events associated with smoking among patients with diabetes: meta-analysis of observational prospective studies. Int J Cardiol 2013,167(2),342-350","journal-title":"Int J Cardiol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.115.017926","volume":"132","author":"Pan A.","year":"2015","unstructured":"Pan A.; Wang Y.; Talaei M.; Hu F.B.; Relation of smoking with total mortality and cardiovascular events among patients with diabetes mellitus: A meta-analysis and systematic review. Circulation 2015,132(19),1795-1804","journal-title":"Circulation"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jama.2014.18574","volume":"313","author":"Emdin C.A.","year":"2015","unstructured":"Emdin C.A.; Rahimi K.; Neal B.; Callender T.; Perkovic V.; Patel A.; Blood pressure lowering in type 2 diabetes: A systematic review and meta-analysis. JAMA 2015,313(6),603-615","journal-title":"JAMA"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.2337\/dc16-S003","volume":"39","year":"2016","unstructured":"Standards of medical care in. diabetes-2016: summary of revisions. Diabetes Care 2016,39(Suppl. 1),S4-S5","journal-title":"Diabetes Care"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/01.CIR.94.5.946","volume":"94","year":"1996","unstructured":"Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention Trial. Circulation The Multiple Risk Factor Intervention Trial (MRFIT)1996,94(5),946-951","journal-title":"Circulation"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.2337\/diacare.27.8.1954","volume":"27","author":"Wackers F.J.","year":"2004","unstructured":"Wackers F.J.; Young L.H.; Inzucchi S.E.; Detection of ischemia in asymptomatic diabetics investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004,27(8),1954-1961","journal-title":"Diabetes Care"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1007\/s00330-010-1996-z","volume":"21","author":"Maffei E.","year":"2011","unstructured":"Maffei E.; Seitun S.; Nieman K.; Assessment of coronary artery disease and calcified coronary plaque burden by computed tomography in patients with and without diabetes mellitus. Eur Radiol 2011,21(5),944-953","journal-title":"Eur Radiol"}],"container-title":["Current Cardiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/176549","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/176549\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/176549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T09:58:16Z","timestamp":1638957496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/176549\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573403x15666191111123622","relation":{},"ISSN":["1573-403X"],"issn-type":[{"value":"1573-403X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-11-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}